GHP KISS header photo

Cost-effectiveness of mass drug administration for intestinal worm control

John Paul Caesar Delos Trinos

Event date
Tuesday 19 September 2023
Event time
1:00pm - 2:00pm
Event address
Online

 

Hepatitis B infection is the major cause of liver cancer worldwide. Liver cancers only become detectable decades after the initial infection. A/Prof Tu’s group aims to characterise what occurs during this long pre-cancerous phase to detect risk-factors before cancer forms, and so reduce mortality rates using early interventions.

Cancer risk can be lessened (but not eliminated) with current antiviral therapies. The team has developed novel assays to sensitively detect the drug-resistant forms of the virus. They are now designing therapeutic approaches to disrupt these forms, cure an infection, and eliminate the risk of cancer progression.

 

A spotlight on Global Health: Learn about research and programs aimed at improving health outcomes in areas of need through collaborations in low- and middle-income countries.

School-based targeted preventive chemotherapy, the main control strategy for intestinal worms, excludes adults. Mass drug administration would benefit the entire population but requires greater investment. Utilising cost surveys, systematic review, and economic modelling, this thesis evaluated the cost, effectiveness, and cost-effectiveness of mass drug administration compared with school-based targeted preventive chemotherapy for intestinal worm control in Vietnam and the Philippines.

John Paul Caesar Delos Trinos

John Paul Caesar Delos Trinos
Chief Scientific Officer, metaHealth and Scientia PhD Student, Global Health Program, Kirby Institute

Paul is the chief scientific officer of metaHealth Insights and Innovations; a Philippine consulting firm focused on economic evaluation, management, technology assessment, and analytics for health. He is also a guest professorial lecturer at the De La Salle Health Science Institute, where he teaches health economics and HTA. He is pursuing his PhD in the Global Health Program at the Kirby Institute, examining the cost-effectiveness of preventive chemotherapy for soil-transmitted helminth control.

Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.